영양유전체학 시장 보고서 : 제품별, 검체 유형별, 용도별, 최종 사용자별, 지역별(2026-2034년)

The global nutrigenomics market size reached USD 1,474.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 3,348.9 Million by 2034, exhibiting a growth rate (CAGR) of 9.26% during 2026-2034. The growing awareness about gene-diet interactions and their impact on overall health is stimulating the market.

NUTRIGENOMICS MARKET ANALYSIS:

• Major Market Drivers: Increased availability of genetic testing services catering to consumer's nutritional needs is propelling the market.
• Key Market Trends: The rising demand for wellness solutions that align with individual health goals is fueling tailored nutrition options in the market.
• Competitive Landscape: Some of the major market companies include BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc., and Xcode Life, among many others.
• Geographical Trends: Advanced healthcare infrastructure is elevating the market in North America. Moreover, the increasing consumer inclination toward health and fitness is fueling the market in Asia Pacific. Besides this, strong investments in genetic research are enhancing the market outlook in Europe. Besides this, extensive R&D activities are further augmenting the market in Latin America.
• Challenges and Opportunities: The lack of standardized guidelines is hindering the market. However, increased research and development for interpreting genetic data and making personalized dietary recommendations will continue to catalyze the market over the forecasted period.

NUTRIGENOMICS MARKET TRENDS:

Growing Demand for Personalized Nutrition Solutions

Nutrigenomics is increasingly used to create personalized diets based on an individual's genetic makeup, helping to optimize health and prevent disease. This approach shifts away from generalized nutrition plans, offering tailored solutions that align with unique biological needs for better outcomes. For instance, in August 2024, Avesthagen and Apollo AyurVAID partnered to launch "AvestaAyurVAID," integrating Ayurveda with nutrigenomics to create personalized medical foods and dietary supplements. This collaboration aims to address specific nutritional needs for chronic diseases, promoting scientifically validated, plant-based solutions for proactive health management. According to the nutrigenomics market forecast report, this is acting as a significant growth-inducing factor.

Integration of AI and Genetic Data

The combination of AI and genetic analysis allows for more accurate and actionable nutritional recommendations. AI helps in understanding complex gene-diet interactions by analyzing large datasets, thereby enabling more precise interventions for improving health through personalized dietary changes. For instance, in July 2024, Vieroots Wellness Solutions introduced the EPLIMO program, combining AI and genetic science to offer personalized wellness plans based on nutrigenomics. This initiative uses genetic data to suggest diet, supplements, and lifestyle changes, aiming to reduce disease risks and promote optimal health. This is escalating the nutrigenomics market demand.

Increased Focus on Chronic Disease Management

Nutrigenomics plays a crucial role in managing chronic conditions by offering targeted nutrition plans that can mitigate disease risks. Moreover, personalized diets are becoming a key tool in addressing issues like diabetes, cardiovascular disease, and obesity, helping individuals manage these conditions more effectively through tailored nutritional strategies. For instance, in August 2024, the GENEY program was launched to promote precision nutrition among youth, focusing on integrating genetic insights with dietary education. The initiative aims to address obesity and non-communicable diseases by fostering awareness of nutrigenomics in schools and encouraging healthier lifestyle choices among students.

GLOBAL NUTRIGENOMICS INDUSTRY SEGMENTATION:

Breakup by Product:

• Reagents and Kits
• Services

Nutrigenomics reagents and kits and services support genetic testing and analysis for personalized nutrition. These products help identify gene-diet interactions, enabling tailored dietary recommendations. In addition, services often include genetic profiling, data interpretation, and personalized wellness plans to optimize health through nutrition based on individual genetic markers. This is expanding the nutrigenomics market outlook.

Breakup by Sample Type:

• Saliva
• Buccal Swab
• Blood
• Others

Nutrigenomics uses various sample types, such as saliva, buccal swabs, and blood, to analyze genetic data. Saliva and buccal swabs are non-invasive methods, while blood provides more detailed genomic information. These samples help create personalized nutrition plans based on genetic profiles to optimize health outcomes. This is escalating the nutrigenomics market share.

Breakup by Application:

• Cardiovascular Diseases
• Obesity
• Cancer Research
• Others

Nutrigenomics studies the relationship between genetics and diet, focusing on how individual genetic variations influence the risk of cardiovascular diseases, obesity, and cancer, thereby enabling personalized nutritional interventions for improved health outcomes.

Breakup by End User:

• Dieticians
• Sport Clinics
• Corporate Programs
• Others

As per the nutrigenomics market outlook report, dieticians play a vital role in tailoring dietary plans based on genetic profiles, enhancing health outcomes. In contrast, sport clinics leverage this approach to optimize athletic performance, while corporate programs focus on personalized nutrition for employee wellness and productivity.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

As per the nutrigenomics market analysis report, in Asia Pacific, the market is growing rapidly due to increasing health awareness and rising disposable incomes. In contrast, Europe emphasizes personalized nutrition regulations and research initiatives, while North America leads in technological advancements and consumer adoption. Apart from this, Latin America shows potential with growing interest in wellness, and the Middle East and Africa are expanding, driven by rising obesity rates and healthcare investments.

COMPETITIVE LANDSCAPE:

The nutrigenomics market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• BASF SE
• Cell-Logic
• Cura Integrative Medicine
• Danone S.A
• Fagron
• Genova Diagnostics
• Holistic Health International
• Koninklijke DSM N.V.
• Metagenics Inc.
• Nutrigenomix Inc.
• Xcode Life

KEY QUESTIONS ANSWERED IN THIS REPORT

• How has the global nutrigenomics market performed so far, and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global nutrigenomics market growth?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the sample type?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global nutrigenomics market, and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Nutrigenomics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Reagents and Kits
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

• 7.1 Saliva
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Buccal Swab
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Blood
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Cardiovascular Diseases
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Obesity
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cancer Research
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Dieticians
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Sport Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Corporate Programs
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 BASF SE
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Cell-Logic
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Cura Integrative Medicine
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Danone S.A
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Fagron
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
  • 15.3.6 Genova Diagnostics
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Holistic Health International
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Koninklijke DSM N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Metagenics Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Nutrigenomix Inc.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Xcode Life
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio